Collegium Pharmaceutical
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell COLL and other ETFs, options, and stocks.About COLL
Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic.
COLL Key Statistics
Stock Snapshot
With a market cap of 1.44B, Collegium Pharmaceutical(COLL) trades at $45.53. The stock has a price-to-earnings ratio of 28.82.
As of 2026-01-03, Collegium Pharmaceutical(COLL) stock has fluctuated between $45.06 and $46.39. The current price stands at $45.53, placing the stock +1.0% above today's low and -1.9% off the high.
The Collegium Pharmaceutical(COLL)'s current trading volume is 318.94K, compared to an average daily volume of 453.54K.
In the last year, Collegium Pharmaceutical(COLL) shares hit a 52-week high of $50.79 and a 52-week low of $23.23.
In the last year, Collegium Pharmaceutical(COLL) shares hit a 52-week high of $50.79 and a 52-week low of $23.23.
COLL News
Collegium Pharmaceutical (COLL) announced the closing of its inaugural syndicated credit facility. The new aggregate $980M credit facility will mature in 2030 a...